SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2021-07-08 16:43
Tx date 2021-07-07 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-32,814
-3,646 vol
$9.00 each 		0
Filed 2021-07-08 16:42
Tx date 2021-07-07 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$1,385
+3,646 vol
$0.38 each 		3,646
Filed 2021-07-08 16:40
Tx date 2021-07-07 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-1,385.48
-3,646 vol
$0.38 each 		81,427
Filed 2021-06-08 17:49
Tx date 2021-06-07 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-30,152.42
-3,646 vol
$8.27 each 		0
Filed 2021-06-08 17:48
Tx date 2021-06-07 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$1,385
+3,646 vol
$0.38 each 		3,646
Filed 2021-06-08 17:45
Tx date 2021-06-07 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-1,385.48
-3,646 vol
$0.38 each 		85,073
Filed 2021-05-10 17:20
Tx date 2021-05-07 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-33,907.80
-3,646 vol
$9.30 each 		0
Filed 2021-05-10 17:19
Tx date 2021-05-07 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$1,385
+3,646 vol
$0.38 each 		3,646
Filed 2021-05-10 17:17
Tx date 2021-05-07 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-1,385.48
-3,646 vol
$0.38 each 		88,719
Filed 2021-04-09 17:11
Tx date 2021-04-07 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-39,449.72
-3,646 vol
$10.82 each 		0
Filed 2021-04-09 17:10
Tx date 2021-04-07 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$1,385
+3,646 vol
$0.38 each 		3,646
Filed 2021-04-09 17:09
Tx date 2021-04-07 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-1,385.48
-3,646 vol
$0.38 each 		92,365
Filed 2021-03-15 14:36
Tx date 2021-03-12 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-34,916.49
-2,917 vol
$11.97 each 		0
Filed 2021-03-15 14:34
Tx date 2021-03-12 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$12,338
+2,917 vol
$4.23 each 		2,917
Filed 2021-03-15 14:31
Tx date 2021-03-12 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-12,338.91
-2,917 vol
$4.23 each 		96,011
Filed 2021-03-10 13:47
Tx date 2021-03-08 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-36,861.06
-3,646 vol
$10.11 each 		0
Filed 2021-03-10 13:47
Tx date 2021-03-08 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$1,385
+3,646 vol
$0.38 each 		3,646
Filed 2021-03-10 13:44
Tx date 2021-03-08 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-1,385.48
-3,646 vol
$0.38 each 		98,928
Filed 2021-02-10 20:38
Tx date 2021-02-09 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-8,248.416
-584 vol
$14.12 each 		0
Filed 2021-02-10 20:37
Tx date 2021-02-09 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$7,136
+584 vol
$12.22 each 		584
Filed 2021-02-10 20:36
Tx date 2021-02-09 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-7,136.48
-584 vol
$12.22 each 		102,574
Filed 2021-02-10 20:35
Tx date 2021-02-08 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-36,900.05
-2,917 vol
$12.65 each 		0
Filed 2021-02-10 20:34
Tx date 2021-02-08 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$12,338
+2,917 vol
$4.23 each 		2,917
Filed 2021-02-10 20:33
Tx date 2021-02-08 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-12,338.91
-2,917 vol
$4.23 each 		103,158
Filed 2021-02-10 20:31
Tx date 2021-02-08 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-46,121.90
-3,646 vol
$12.65 each 		0
Filed 2021-02-10 20:30
Tx date 2021-02-08 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$1,385
+3,646 vol
$0.38 each 		3,646
Filed 2021-02-10 20:29
Tx date 2021-02-08 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-1,385.48
-3,646 vol
$0.38 each 		106,075
Filed 2021-01-12 19:42
Tx date 2021-01-11 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-8,878.6688
-584 vol
$15.20 each 		0
Filed 2021-01-12 19:41
Tx date 2021-01-11 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$7,136
+584 vol
$12.22 each 		584
Filed 2021-01-12 19:40
Tx date 2021-01-11 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-7,136.48
-584 vol
$12.22 each 		109,721
Filed 2021-01-12 19:39
Tx date 2021-01-08 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-45,230.4186
-2,917 vol
$15.51 each 		0
Filed 2021-01-12 19:38
Tx date 2021-01-08 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$12,338
+2,917 vol
$4.23 each 		2,917
Filed 2021-01-12 19:37
Tx date 2021-01-08 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-12,338.91
-2,917 vol
$4.23 each 		110,305
Filed 2021-01-12 19:36
Tx date 2021-01-08 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-88,575.20
-5,600 vol
$15.82 each 		0
Filed 2021-01-12 19:32
Tx date 2021-01-08 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$78,288
+5,600 vol
$13.98 each 		5,600
Filed 2021-01-12 19:31
Tx date 2021-01-08 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-78,288
-5,600 vol
$13.98 each 		113,222
Filed 2021-01-12 16:58
Tx date 2021-01-07 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-53,782.146
-3,646 vol
$14.75 each 		0
Filed 2021-01-12 16:56
Tx date 2021-01-07 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$1,385
+3,646 vol
$0.38 each 		3,646
Filed 2021-01-12 16:55
Tx date 2021-01-07 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-1,385.48
-3,646 vol
$0.38 each 		118,822
Filed 2021-01-04 13:45
Tx date 2020-12-31 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-307,104.684
-21,621 vol
$14.20 each 		0
Filed 2021-01-04 13:43
Tx date 2020-12-31 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$264,208
+21,621 vol
$12.22 each 		21,621
Filed 2021-01-04 13:42
Tx date 2020-12-31 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-264,208.62
-21,621 vol
$12.22 each 		122,468
Filed 2020-12-28 16:30
Tx date 2020-12-23 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+250,000 vol 		386,795
Filed 2020-12-18 21:18
Tx date 2020-12-18 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-264,489.7332
-21,693 vol
$12.19 each 		0
Filed 2020-12-18 21:17
Tx date 2020-12-18 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$8,243
+21,693 vol
$0.38 each 		21,693
Filed 2020-12-18 21:16
Tx date 2020-12-18 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-8,243.34
-21,693 vol
$0.38 each 		144,089
Filed 2020-12-18 21:15
Tx date 2020-12-17 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-304,694.6398
-25,702 vol
$11.85 each 		0
Filed 2020-12-18 21:14
Tx date 2020-12-17 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$9,766
+25,702 vol
$0.38 each 		25,702
Filed 2020-12-18 21:13
Tx date 2020-12-17 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-9,766.76
-25,702 vol
$0.38 each 		165,782
Filed 2020-12-18 21:12
Tx date 2020-12-17 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-802,363.3418
-67,682 vol
$11.85 each 		0
Filed 2020-12-18 21:11
Tx date 2020-12-17 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$52,115
+67,682 vol
$0.77 each 		67,682
Filed 2020-12-18 21:07
Tx date 2020-12-17 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-52,115.14
-67,682 vol
$0.77 each 		191,484
Filed 2020-12-18 21:06
Tx date 2020-12-16 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-796,296.501
-69,069 vol
$11.53 each 		0
Filed 2020-12-18 21:05
Tx date 2020-12-16 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$53,183
+69,069 vol
$0.77 each 		69,069
Filed 2020-12-18 21:04
Tx date 2020-12-16 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-53,183.13
-69,069 vol
$0.77 each 		259,166
Filed 2020-12-18 21:03
Tx date 2020-12-15 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-154,085.87
-13,249 vol
$11.63 each 		0
Filed 2020-12-18 21:02
Tx date 2020-12-15 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$10,201
+13,249 vol
$0.77 each 		13,249
Filed 2020-12-18 21:01
Tx date 2020-12-15 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-10,201.73
-13,249 vol
$0.77 each 		328,235
Filed 2020-12-18 20:58
Tx date 2020-12-15 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-672,609.42
-57,834 vol
$11.63 each 		0
Filed 2020-12-18 20:57
Tx date 2020-12-15 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$244,637
+57,834 vol
$4.23 each 		57,834
Filed 2020-12-18 20:55
Tx date 2020-12-15 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-244,637.82
-57,834 vol
$4.23 each 		341,484
Filed 2020-12-18 19:36
Tx date 2020-12-14 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-177,135.0736
-15,082 vol
$11.74 each 		0
Filed 2020-12-18 19:34
Tx date 2020-12-14 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$63,796
+15,082 vol
$4.23 each 		15,082
Filed 2020-12-18 19:33
Tx date 2020-12-14 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-63,796.86
-15,082 vol
$4.23 each 		399,318
Filed 2020-12-18 19:32
Tx date 2020-12-14 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-99,842.5448
-8,501 vol
$11.74 each 		0
Filed 2020-12-18 19:31
Tx date 2020-12-14 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$63,757
+8,501 vol
$7.50 each 		8,501
Filed 2020-12-18 19:30
Tx date 2020-12-14 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-63,757.50
-8,501 vol
$7.50 each 		414,400
Filed 2020-12-18 19:29
Tx date 2020-12-14 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-395,952.4424
-33,713 vol
$11.74 each 		0
Filed 2020-12-18 19:28
Tx date 2020-12-14 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$281,166
+33,713 vol
$8.34 each 		33,713
Filed 2020-12-18 19:27
Tx date 2020-12-14 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-281,166.42
-33,713 vol
$8.34 each 		422,901
Filed 2020-12-18 19:26
Tx date 2020-12-14 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-245,595.5128
-20,911 vol
$11.74 each 		0
Filed 2020-12-18 19:25
Tx date 2020-12-14 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$192,381
+20,911 vol
$9.20 each 		20,911
Filed 2020-12-18 19:23
Tx date 2020-12-14 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-192,381.20
-20,911 vol
$9.20 each 		456,614
Filed 2020-12-18 19:21
Tx date 2020-12-14 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-494,056.7568
-42,066 vol
$11.74 each 		0
Filed 2020-12-18 19:20
Tx date 2020-12-14 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$435,383
+42,066 vol
$10.35 each 		42,066
Filed 2020-12-18 19:19
Tx date 2013-04-09 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-18 19:18
Tx date 2020-12-14 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-435,383.10
-42,066 vol
$10.35 each 		477,525
Filed 2020-12-18 18:04
Tx date 2020-09-29 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
90 - Change in the nature of ownership
+519,591 vol 		519,591
Filed 2020-12-18 18:01
Tx date 2013-04-09 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-18 18:00
Tx date 2020-09-29 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
90 - Change in the nature of ownership
-519,591 vol 		136,795
Filed 2020-12-18 17:53
Tx date 2020-09-29 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
90 - Change in the nature of ownership
-519,591 vol
Filed 2020-12-18 17:53
Tx date 2013-04-09 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-18 17:22
Tx date 2013-04-09 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-18 17:21
Tx date 2020-09-29 		$TRIL
Trillium Therapeutics Inc. 		Uger, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
90 - Change in the nature of ownership
-519,591 vol
Filed 2019-11-12 10:42
Tx date 2019-11-07 		$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) 		Uger, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$66,500
+175,000 vol
$0.38 each 		656,386
Filed 2019-05-27 12:51
Tx date 2019-05-10 		$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) 		Uger, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$115,500
+150,000 vol
$0.77 each 		481,386
Filed 2018-11-09
Tx date 2018-11-08 		$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) 		Uger, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$592,200
+140,000 vol
$4.23 each 		331,386
Filed 2017-11-13
Tx date 2017-11-09 		$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) 		Uger, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$342,758
+28,049 vol
$12.22 each 		191,386
Filed 2016-11-10
Tx date 2016-11-09 		$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) 		Uger, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$192,381
+20,911 vol
$9.20 each 		163,337
Filed 2016-05-30
Tx date 2016-05-27 		$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) 		Uger, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+29,073 vol 		142,426
Filed 2015-11-20
Tx date 2015-11-19 		$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) 		Uger, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+29,073 vol 		113,353
Filed 2015-05-22
Tx date 2014-11-14 		$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) 		Uger, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-1,011,361 vol 		50,568
Filed 2015-05-22
Tx date 2014-11-14 		$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) 		Uger, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
+42,067 vol 		1,061,929
Filed 2015-05-22
Tx date 2014-11-14 		$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) 		Uger, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-1,262,013 vol 		1,019,862
Filed 2015-05-22
Tx date 2014-11-14 		$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) 		Uger, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
+8,501 vol 		2,281,875
Filed 2015-05-22
Tx date 2014-11-14 		$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) 		Uger, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-255,028 vol 		2,273,374
Filed 2015-05-22
Tx date 2014-11-14 		$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) 		Uger, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
+33,712 vol 		84,280